New end-to-end compliant-ready workflow helps biotherapeutic protein manufacturers meet regulatory and attribute-based product analysis requirements for drug identity, purity, and quality
Researchers have developed a new method that identifies double-bridged peptides that bind a disease target of interest and survive enzymes of the gastrointestinal tract
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.